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Abstract
Background-Whereas the presence of a
lymphoid infiltrate has been associated
with a favourable prognosis in colorectal
carcinoma, the proliferative and cytotoxic
responses of freshly isolated tumour
infiltrating lymphocytes are frequently
impaired. In mice, tumour induced
immune suppression has been associated
with a decreased expression ofthe c-chain
of the T cell receptor (TCR)-CD3 com-
plex, and loss ofmRNA for granzyme B.
Aim-To compare the expression of
TCR-C and granzyme B in lymphocytes
infiltrating normal colonic mucosa and
Dukes's A and D colorectal carcinomas.
Specimens-Paraffin wax embedded nor-
mal (n=10) and malignant colonic mucosa
(seven Dukes's A, nine Dukes's D).
Method-Immunohistochemistry.
Results-The numbers of TCR-t' lym-
phocytes decreased from normal mucosa
to Dukes's D carcinomas. In contrast,
granzyme B' lymphocytes were more
frequent in Dukes's A carcinomas than in
normal mucosa, but disappeared from
advanced stage tumours. Granzyme B
expressing cells were mainly CD3-
(natural killer/lymphokine activated killer
cells) in normal mucosa, but CD3+ in
tumours, indicating the presence of acti-
vated cytotoxic T lymphocytes. In vitro
culture oftumour infiltrating lymphocytes
rapidly restored the expression of both
molecules.
Conclusion-The frequency of TCR-C'
and granzyme B' lymphocytes is de-
creased in advanced stage colorectal
carcinomas. The restoration ofexpression
during in vitro stimulation suggests the
presence of tumour derived suppressive
factors in situ.
(Gut 1997; 40: 113-119)
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In several tumours, including colorectal carcin-
oma, the presence of a lymphoid infiltrate has
been associated with a favourable prognosis.1 2
It is assumed that these tumour infiltrating
lymphocytes reflect the host's immune
response against the tumour cells. The
increased precursor frequencies of tumour
specific cytotoxic T lymphocytes in some
tumours in comparison with peripheral blood
mononuclear cells (PBMC) strengthens this
hypothesis.' However, although tumour
infiltrating lymphocytes can effectively kill
autologous tumour cells in vitro stimulation
and expansion,4 5 proliferative and cytotoxic
responses of freshly isolated tumour infiltrating
lymphocytes are frequently impaired.3 6
In tumour bearing mice it has been
demonstrated that a loss of two important
signal transduction molecules in T lympho-
cytes, the T cell receptor (TCR)-t chain and
p56lck, could be the basis of this functional
deficit.7 The TCR-C chain is a disulphide
linked homodimer associated with the CD3
complex. Its cytoplasmatic domain is involved
in signal transduction and subsequent ac-
tivation of T cells.8 9 Recently, two groups
independently reported that the expression of
TCR-t in peripheral blood lymphocytes and in
tumour infiltrating lymphocytes from patients
with renal cell carcinoma and colorectal car-
cinoma is decreased compared with peripheral
blood lymphocytes from healthy subjects.'01
Subsequent investigations by Matsuda et al
demonstrated that lymphocytes infiltrating
normal colon mucosa derived from colorectal
cancer patients also have decreased expression
of TCR-( compared with peripheral blood
lymphocytes.'2 They showed that the intensity
ofTCR-t staining on isolated lymphocytes was
inversely related to their distance from the
tumour, with mucosal lymphocytes in the
proximity of the tumour expressing less TCR-C
than lymphocytes obtained from mucosa at a
greater distance from the tumour. They
hypothesised that this reduction in TCR-C
expression might be caused by soluble factors,
produced by the tumour cells.'2
Granzyme containing lymphocytes have been
demonstrated at sites of acute inflammation.'3
Granzymes have a pivotal role in exocytosis
mediated cytotoxic processes.'4 These serine
proteases are constituents of the so called
'cytotoxic granules' in cytotoxic T lymphocytes
and natural killer cells.'5 Granzyme B is the
most abundant granzyme in cytotoxic T
lymphocytes. As in vitro stimulation with
interleukin 2 (IL2) or phorbol myristate
acetate (PMA) in combination with anti-CD3
rapidly induces messenger RNA for granzymes
in peripheral blood T lymphocytes,'6 the
expression of granzymes can be considered as
a sign of T cell activation. In tumour bearing
mice, the impaired cytotoxic capacity of CD8+
lymphocytes has been associated with a delay
and a decrease in the expression of mRNA
granzyme for granzyme B.'7
In this study we analysed the expression
of TCR-; and granzyme B in situ in T
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lymphocytes infiltrating early and late stage
colorectal carcinomas (Dukes's A and D) using
immunohistochemical methods. For com-
parison, normal colon mucosa specimens
from non-cancer patients were examined. In
Dukes's D colon carcinomas the density of the
CD3+ lymphocyte infiltration was decreased in
comparison with Dukes's A carcinoma and
normal mucosa, whereas granzyme B express-
ing T lymphocytes were most frequent in early
stage tumours, but decreased in late stage
tumours. This is probably due to tumour
derived suppressive influences as both TCR-(
and granzyme B expression were restored upon
in vitro stimulation of the tumour infiltrating
lymphocytes.
Methods
Specimens
Formalin fixed, paraffin wax embedded ma-
terial was obtained from primary colorectal
carcinomas (seven Dukes's A, nine Dukes's
D). Formalin fixed, paraffin wax embedded
specimens of normal colonic mucosa were
obtained from surgical specimens after correc-
tion of an anus praeter (n=4), or from biopsy
specimens that were taken because of a
suspicion of Hirschsprung's disease (n=6).
Antibodies
The anti-TCR-t monoclonal antibody (mAb)
TIA-2 (IgGl; Coulter Immunology, Hialeah,
USA) recognises an intracytoplasmatic epitope
on the 4-chain of the TCR complex and in
natural killer cells."8 The murine GB7 mAb
(IgG2a) recognises human granzyme B in for-
malin fixed paraffin wax embedded tissues."9
AntiCD8 (CD8/144, IgGI20) was a kind gift of
Dr D Y Mason, Oxford. Rabbit polyclonal
anti-CD3 recognises the E-chain of the CD3
complex and was purchased from Dakopatts
(Glostrup, Denmark).
Immunohistochemistry
Four ,m thick tissue sections were mounted
on poly-L-lysine coated glass slides and air
dried. Endogenous peroxidase activity was
blocked by incubation in 03% H202/methanol
for 30 minutes. To optimise the immuno-
reactivity of the epitopes, antigens were
'retrieved' as described previously.2' Briefly,
tissue sections were immersed in sodium
citrate buffer (0 1 M, pH 6 0) and boiled for
10 minutes followed by a 20 minute period of
cooling down. After intensive washing in tap
water followed by phosphate buffer saline
(PBS), staining was performed using the
biotin-streptavidin technique (ABC). Staining
was developed with diaminobenzidine (Sigma
Chemical, St Louis, MO) and the tissue sec-
tions were counterstained with haematoxylin.
Double staining with GB7
Double staining was performed for granzyme
B in combination with CD3 or with CD8,
according to the procedure as described by
Merchenthaler.22 Briefly, after a pre-incubation
in normal saline solution, both antibodies were
incubated simultaneously in the appropriate
dilution. After washing in saline sodium citrate
buffer (SSC) and PBS, detection of granzyme
B was performed using biotinylated goat
antimouse-IgG2a followed by a horseradish
peroxidase labelled streptavidin. Staining was
developed with diaminobenzidine/Ni/H202
(1-5 ml NiSO2(NH2)2SO4 *6H20 4% in 50 ml
TRIS buffer 0 05 M) resulting in a grey-black
staining (DAB/Ni, Sigma Chemical, St Louis,
MO). Remaining peroxidase activity was
inhibited by incubation in 0-3% H202
methanol for 15 minutes. After mild fixation
using 4% paraformaldehyde (two minutes)
anti-CD8 and anti-CD3 staining procedures
were performed using the ABC technique and
developed with DAB resulting in the normal
brown colour. If necessary, GB7 staining was
increased by silver enhancement.22
Lymphocyte culturing
Healthy donor peripheral blood lymphocytes
were isolated by Ficoll Hypaque gradient
(Pharmacia, Uppsala, Sweden) using standard
procedures. Tumour infiltrating lymphocytes
were obtained from colorectal carcinoma cell
suspensions that were prepared from primary
colon carcinomas as described previously23 and
cryopreserved in liquid nitrogen. Before use,
tumour cell suspensions were rapidly thawed
and gradually diluted in Hank's balanced salt
solution containing 0O02% DNase. After
washing in Hank's balanced salt solution,
peripheral blood lymphocytes and tumour
infiltrating lymphocytes were cultured at 1 X
106 cells per ml in Iscove's modified
Dulbecco's medium supplemented with 10%
fetal calf serum, 50 IU/ml penicillin, 50 ,ug/ml
streptomycin, 2 mM glutamin, and 50 ,uM
,B-mercapto-ethanol. The lymphocytes were
polyclonally activated using a combination of
mAbs to CD3 and CD2824 with 10 IU/ml IL2
(Cetus, Emeryville, CA, USA).
Cytospin preparations were prepared using
4X104 cells per cytospin, air dried, and fixed
in 4% buffered formalin for 10 minutes. When
the cytospin preparations were not stained
immediately, they were dehydrated, air dried,
and stored at room temperature until further
use.
Evaluation
Quantification of immunolabelled cells was
done by counting positively stained lymphoid
cells in 10 high power fields (400X) within the
tumour area. The fields were randomly chosen
and had to contain at least 75% tumour cell
surface. For granzyme B, the proportion of
double stained cells was assessed by counting
at least 100 granzyme B+ cells and scoring
whether they were double or single stained.
When less than 100 granzyme B+ cells were
present, all granzyme B+ cells in the tumour
area were counted. Statistical analysis of the
data was performed by the Mann-Whitney U
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TABLE I Median (range) of the number oflymphocytes infiltrating 10 high powerfields (400X) of normal colon mucosa
and Dukes's A and D carcinoma
Significance level*
Normal mucosa Dukes'sA Dukes's D
(n=10) (n=7) (n=9) AvN DvN DvA
CD3+ 421 (171-1477) 511 (341-810) 235 (214-484) 0 49 0-08 0-01
CD8+ 191 (35-463) 119 (33-415) 60 (11-246) 0 77 0-02 0 11
TCR-4-t 113 (59-1073)t 78 (7-316)t 28 (3-105)t 0-12 0 01 0-12
Granzyme B+ 9 (2-46) 34 (6-68) 5 (0-60) 0-03 0-31 0 01
CD3+/granzyme B+ 3 (1-7) 30 (4-55) 3 (0-41) 0 01 0 49 0 09
*p Values were calculated by Mann-Whitney U test for the differences between Dukes's A v normal mucosa (A v N), Dukes's D v
normal mucosa (D v N), and Dukes's D v Dukes's A (D v A). tNormal mucosa: n=6; Dukes's A: n=5; Dukes's D: n=7.
test. Two tailed p values lower than 0'05 were
considered significant.
Results
CD3+ and CD8+ lymphocytes
Table I summarises the composition of the
mononuclear infiltrates in Dukes's A and D
colon carcinoma in comparison with normal
colon mucosa from non-cancer patients. In
normal and malignant tissues, a large variation
was observed between different donors in the
numbers of lymphocytes expressing each of the
markers. In normal mucosa, a median number
of 421 CD3+ lymphocytes was counted in 10
high power fields (HPF, 400X). The numbers
ofCD3+ lymphocytes in Dukes's A carcinomas
were slightly higher than in normal mucosa
(median 511). In contrast, Dukes's D
carcinomas contained less CD3+ cells per 10
HPF than normal mucosa and Dukes's A
tumours. The difference with Dukes's A
tumours was significant (Dukes's D v Dukes's
A: p=0 01; Table I). In comparison with
normal mucosa, the numbers of CD8+ cells
were somewhat lower in Dukes's A tumours
(Dukes's A: median 119; normal mucosa:
median 191; Table I). In Dukes's D
carcinomas both the absolute numbers of
CD8+ cells (median number 60; Dukes's D v
normal: p=002; Table I) and their percentages
compared with CD3+ cells were lower than in
normal mucosa: 20-60% of the CD3+
lymphocytes in normal mucosa were CD8+
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(median 35%), whereas in Dukes's D tumours
the median percentage of CD8+ lymphocytes
was 12% (p=0 04; Fig IA).
TCR-4+ lymphocytes
The expression of TCR-; was analysed in the
same mononuclear infiltrates. As shown in
Table I, both in normal mucosa and carcinoma
specimens the numbers of TCR-t expressing
cells were always substantially lower than
the number of CD3+ lymphocytes. It was
discounted that the difference between the
numbers of CD3+ and TCR-4+ lymphocytes
were due to the immunohistochemical pro-
cedure because T lymphocytes surrounding
lymphoid follicles present in the mucosa
showed equal numbers of TCR-4+ and CD3+
lymphocytes (Fig 2A and B). Despite the
interindividual variability, the median numbers
of TCR-t' lymphocytes were significantly
lower in Dukes's D carcinomas (n=7, median
28) than in normal mucosa (n=6, median 113;
Dukes's D v normal: p=0 01, Dukes's A+D v
normal p=0 01; Table I). Calculated as a
proportion of the number of CD3+ cells, the
percentage of TCR-4+ lymphocytes was lower
in tumour tissue than in normal mucosa
(medians: 17% v 50%), but due to the high
interindividual variability this difference was
not statistically significant (Fig 1B). Figure 2C
and D shows consecutive tissue sections of a
Dukes's D colon carcinoma stained for CD3
(C) and TCR-; (D).
_B TCR-~Granzyme B expressionThe mononuclear infiltrates were also exam-
ined for the expression of granzyme B, as
shown in Table I. In normal mucosa as well as
in Dukes's D carcinoma, very low numbers of
* granzyme B+ cells were found (Table I). In
* ; general, they were located in the lamina
-* propria, and had the morphology of large
* granular lymphocytes (Fig 2E). The median
number of granzyme B expressing cells in
Dukes's A carcinomas (median 34) was
significantly higher compared with normal
* mucosa (median 9) and Dukes's D carcinomas
: -- *;(median 3) (Dukes's A v normal: p=003,
Dukes's A v Dukes's D: p=001; Table I).
0** Double staining for granzyme B and CD3
N A D and for granzyme B and CD8 showed that
most of the granzyme B+ cells in Dukes's A and
A)o anpad Dwkth the numberof D carcinomas also expressed CD3 and CD8,
roup. Statistical differences were indicating that these cells were activated
cytotoxic T lymphocytes (CD3+ granzyme B+:
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Figure 1: Percentages ofCD8+ and TCR-t' lymphocyte
CD3+ lymphocytes in normal mucosa (N), Dukes's A (
carcinoma. Bars represent median values within each gi
calculated using the Mann-Whitney U test.
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median 68%; CD8+ granzyme B+: median
65%; Table II). In contrast, in normal colon
mucosa most of the granzyme B+ cells were
negative for CD3 and CD8, which indicates a
A
high amount of natural killer cells present
(CD3+ granzyme B+: median 32%; CD8+
granzyme B+: median 25%; Table II). Figure
2 E and F shows examples of double staining
B
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Figure 2: TCR-t and granzyme B expression in normal colonic mucosa and colorectal carcinomas. Mucosa associatedlymphoidfollicle stained with CD3 (A) and TCR-t (B). CD3 (C) and TCR-{ (D) expression in sequential tissue sections
ofa Dukes's D carcinoma. Double stainingfor CD3 and granzyme B in normal colonic mucosa (E) and Dukes's A
carcinoma (F).
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TABLE II Phenotype ofgranzyme B expressing lymphocytes in normal colonic mucosa and
colorectal carcinomas
Double positive cells as Normal mucosa Tumour
% ofgranzyme B+ cels (median % (range)) (median % (range)) p Value
CD3+/granzyme B+ 32 (6-58) 68 (12-82) 0-002
(n=10) (n=13)
CD8+/granzyme B+ 25 (0-48) 65 (36-90) 0-02
(n=6) (n=5)
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Figure 3: Proportions of Tlymphocytes expressing
granzyme B in normal colonic mucosa (N), Dukes'sA (A)
and Dukes's D (D) carcinoma. Bars represent median
values within each group. Statistical differences were
calculated using the Mann-Whitney U test.
for CD3 and granzyme B in normal and
tumour tissue. Figure 3 shows that in Dukes's
A tumours the proportion of CD3' lympho-
cytes containing granzyme B was significantly
higher than in normal colonic mucosa
(Dukes's A v normal: p=O0Ol; Fig 3).
In vitro culture oftumour infiltrating cells
To analyse whether the low TCR-t expression
in tumour infiltrating lymphocytes was a stable
trait, we investigated whether it could be
restored upon stimulation in vitro with a
Day 0
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A TCR-;+ B Granzyme B+
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C P60 60
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Figure 4: Increase in the percentage of TCR-t+ (A) andgranzyme B+ (B) Tlymphocytes
in peripheral blood lymphocytes and tumour infiltrating lymphocyte cultures after a seven
day culture period with a combination ofmAbs to CD3 and CD28.
combination of stimulatory rnAbs to CD3 and
CD28. TCR-t expression was not affected by
the enzymatical dissociation procedure (data
not shown). For comparison, peripheral blood
lymphocytes from a healthy donor were
stimulated in the same way. Figure 4A shows
that whereas in peripheral blood lymphocytes
approximately all CD3+ lymphocytes ex-
pressed TCR-t', the proportion of CD3+
tumour infiltrating lymphocytes expressing
TCR-t' was below 25%. Upon stimulation
with anti-CD3 and anti CD28, the proportion
of TCR-t' cells significantly increased in all
tumour infiltrating lymphocyte cultures, and
reached a level comparable to cultured peri-
pheral blood lymphocytes. In addition, gran-
zyme B expression was induced in 300/o-70%
of CD3+ tumour infiltrating lymphocytes
(Fig 4B). Seven days after initiation of the
culture, virtually all granzyme B+ cells were
T lymphocytes as demonstrated by CD3
reactivity (data not shown).
Discussion
Upon stimulation of the TCR complex,
phosphorylation of the TCR-t chain is an
essential step in the intracellular signalling
pathway leading to T lymphocyte activation.8
Recently it was observed that T cells from
tumour bearing mice lacked the CD3-C chain
and exhibited impaired cytotoxic function and
a decreased ability to mediate an antitumour
response, which was associated with a decrease
in the expression of granzyme B mRNA.7 17 In
humans, tumour infiltrating lymphocytes from
renal cell carcinoma and colorectal carcinoma
showed a pronounced decrease in the
expression of TCR-t. 102 In this study, we
observed that the numbers of TCR-t'
lymphocytes in human Dukes's A and D
colorectal carcinomas were lower than in
normal mucosa of non-cancer patients. In
addition, activated granzyme B+ cytotoxic T
lymphocytes were less frequently present in
Dukes's D than in Dukes's A colorectal
carcinomas.
Whereas the numbers of CD3+ infiltrating
cells in Dukes's A tumours were approximately
equal to their numbers in normal colonic
mucosa, CD3+ lymphocytes were decreased in
number in Dukes's D in comparison with
Dukes's A carcinomas. CD8+ lymphocytes
formed a minority of the CD3+ lymphocytes
and their contribution to the infiltrates in
tumour tissue decreased with the tumour stage.
This contradicts the findings ofUmpleby et a125
but confirms those of Norazmi et a126 and
Ostenstadt et a127 who reported a predominance
of CD4+ lymphocytes in colonic tumours.
Compared with normal mucosa, the numbers
of TCR-t expressing lymphocytes in tumours
were decreased in Dukes's A and D colorectal
carcinomas, being lowest in Dukes's D
tumours. This finding adds to the observation
by Matsuda et al that the intensity of TCR-t
staining on the cell membranes of peripheral
blood lymphocytes of colorectal carcinoma
patients decreased with tumour stage."2 More-
over, as the number of TCR-t' lymphocytes
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decreased already in Dukes's A carcinomas,
our results suggest that TCR-t downregulation
in tumour infiltrating lymphocytes is a
comparatively early event in the interaction
between a tumour and the immune system,
which may hamper the adequate activation of
antitumour immune effector cells.
On the other hand we observed an increase
in the numbers of granzyme B expressing
lymphocytes in early stage colorectal tumours
compared with normal colonic mucosa. The
induction of mRNA for perforin and
granzymes in T lymphocytes requires that,
additional to T cell receptor triggering, a co-
stimulatory signal is provided."6 28 Thus, the
presence of granzyme B+ lymphocytes suggests
that some immune stimulation still takes place
in Dukes's A carcinomas. In Dukes's D
carcinomas, however, granzyme B expressing
cells had disappeared from the tumour tissue.
Earlier also Nakanishi et al29 have reported that
perforin expressing lymphocytes may be
present in Dukes's A tumours, but are
decreased with advancing tumour stage. These
data from human colorectal carcinoma are in
line with the findings in mouse models.7 '7
Ochoa et al reported that T lymphocytes from
late (>26 days) tumour bearing mice had an
impaired cytotoxic function combined with a
decreased expression of the tumour necrosis
factor a and granzyme B genes17 and a loss of
TCR-t expression in T lymphocytes.7
The TCR-; chain is required for correct
assembly, transport, and surface expression of
the TCR/CD3 complex.30 In addition, the
TCR-t chain connects the antigen binding
TCR chains with the intracellular signalling
machinery of the T cell.8 A (tumour induced)
defect interfering with the signal transducing
capacity of the TCR-; chain would severely
hamper the function of antitumour immune
effector cells by uncoupling antigen recog-
nition and effector functions. As it has been
demonstrated that colorectal carcinoma cell
lines can produce factors that inhibit T
lymphocyte function,3' 32 it might be envisaged
that tumour cell derived factors cause
progressive decrease in TCR-t expression,
ultimately leading to a decrease in granzyme B
expression. Moreover, the rapid increase in the
expression of both TCR-t and granzyme B
with tumour infiltrating lymphocytes are
stimulated in vitro supports the view that they
are suboptimally activated, or even suppressed
in situ. Further support for tumour induced
immune suppression stems from our finding
that TCR-t expression in healthy donor
peripheral blood lymphocytes is decreased by
incubation in supematants of colon cancer cell
lines (Mulder et al, unpublished results).
Notably, also in normal colonic mucosa, we
observed low numbers of TCR-t expressing
lymphocytes compared with the numbers of
CD3+ cells. This lower expression of TCR-t
was confined to the mucosa. Lymphocytes
surrounding lymphoid follicles present in the
mucosa always expressed TCR-t to the same
extent as CD3. It is not clear what causes the
differences between the numbers of TCR-t'
and CD3+ lymphocytes in normal colonic
mucosa. It could be that it results from local
immunoregulatory influences in the gut,
preventing overactivation of the immune cells
in response to the constant antigenic pressure.
It is tempting to speculate that immuno-
suppressive properties of colorectal carcinoma
cells are malignant derivatives of the immuno-
regulatory function of normal intestinal
epithelial cells.33
In conclusion, this study shows an increase
in the numbers of granzyme B expressing T
lymphocytes in Dukes's A carcinomas in
comparison with normal mucosa suggesting an
initial antitumour immune response. However,
both the numbers of T lymphocytes with a
good TCR-t expression and the numbers of
activated cytotoxicT lymphocytes decreased in
late stage carcinomas. Tumour derived factors
are probably involved because the expression
of both TCR-t and granzyme B by tumour
infiltrating lymphocytes was rapidly restored
during in vitro culture. Whether these findings
reflect the existence of distinct suppressive
mechanisms, and whether the downregulation
of TCR-t and granzyme B expression are
related at the (sub)cellular level should be the
subject of furtier investigations.
The authors thank Dr C J L M Meijer for critical reading of
the manuscript.
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